Other

Capitalized research and development

Parker-Hannifin Capitalized research and development increased by 18.1% to $172.00M in Q2 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Capitalized research and development shows an upward trend with a 36.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ2 2023
Last reportedQ2 2025

How to read this metric

An increase reflects ongoing investment in R&D that is being capitalized for tax purposes, potentially signaling future innovation.

Detailed definition

This represents the tax benefit associated with research and development costs that have been capitalized rather than ex...

Peer comparison

Relevant for companies with high R&D intensity, particularly in aerospace and advanced industrial sectors.

Metric ID: other_deferred_tax_assets_capitalized_research_and_development

Historical Data

3 periods
 Q2 '23Q2 '24Q2 '25
Value$92.19M$145.70M$172.00M
QoQ Change+58.0%+18.1%
YoY Change+58.0%+18.1%
Range$92.19M$172.00M
Avg YoY Growth+38.0%
Median YoY Growth+38.0%
Current Streak2+ quarters growth

Frequently Asked Questions

What is Parker-Hannifin's capitalized research and development?
Parker-Hannifin (PH) reported capitalized research and development of $172.00M in Q2 2025.
What is the long-term trend for Parker-Hannifin's capitalized research and development?
Over 2 years (2023 to 2025), Parker-Hannifin's capitalized research and development has grown at a 36.6% compound annual growth rate (CAGR), from $92.19M to $172.00M.
What does capitalized research and development mean?
The future tax savings resulting from capitalizing R&D expenses instead of deducting them immediately.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.